Enzymes maker Novozymes on Tuesday reported fourth quarter gross sales and earnings barely under expectations however mentioned it anticipated gross sales to bounce again in 2021. Novozymes expects natural gross sales to develop 2-6% in 2021.
www.nasdaq.com
Novozymes expects gross sales to bounce again in 2021
